PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Radium-223 dichloride in prostate cancer: Major added benefit for certain patients

In comparison with BSC: Patients survive longer and get bone symptoms later / no evaluable data in comparison with docetaxel

2014-04-03
(Press-News.org) Radium-223 dichloride (radium-223 for short, trade name: Xofigo) has been approved since November 2013 for men with advanced prostate cancer, in whom hormone blockade is no longer effective, and symptomatic bone metastases, but without visceral metastases. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined whether this new drug offers an added benefit over the appropriate comparator therapy specified by the Federal Joint Committee (G-BA).

No evaluable data were available for the comparison with docetaxel in patients in whom prolongation of life was the primary treatment goal. Hence an added benefit is not proven for this comparison.

Depending on the patients' age and the concomitant treatment (with/without bisphosphonates), there is an indication of major and an indication of minor added benefit of radium-223 compared with best supportive care (BSC).

No valid data for the comparison with docetaxel combination therapy

Radium-223 dichloride is radioactive and mainly accumulates in the bone. By emitting radiation from nearby areas, the drug aims to inhibit bone metastases. The drug should not be used if additional metastases have formed in the organs. The radiation poses no risk for other people.

If prolongation of life was the primary therapeutic objective and the patients were eligible for docetaxel treatment, the G-BA specified docetaxel in combination with prednisone or prednisolone as appropriate comparator therapy (docetaxel population). However, there were no evaluable data for this comparison. Hence an added benefit of radium-223 is not proven for this subpopulation.

BSC as comparator therapy for the treatment goal "symptom control"

If docetaxel treatment was not an option for the patients or if the primary treatment goal was the relief of symptoms, the so-called "symptom control", and the prevention of complications, the G-BA specified BSC as appropriate comparator therapy (BSC population). BSC means a therapy that provides the patient with the best possible individually optimized supportive treatment to alleviate symptoms and improve quality of life. In particular, these include adequate pain therapy, treatment with bisphosphonates and/or radionuclides.

Assessment based on approval study

The benefit assessment of radium-223 compared with BSC was the randomized controlled approval study BC1 06 (ALSYMPCA). 921 patients with an average (median) age of 70 to 71 years participated in this study worldwide. Two thirds of the patients received radium-223 + BSC, the others received placebo + BSC.

The majority of patients included in the study were not eligible for docetaxel because their disease had progressed despite pretreatment with this drug (approximately 57%). It was assumed in the assessment that most of the remaining patients actively decided against docetaxel treatment. The study population was therefore an adequate approximation of the BSC population. Approximately 40% of the patients received concomitant treatment with bisphosphonates.

The BC1 02 study additionally cited by the drug manufacturer was not considered because radium-223 was not used in compliance with its approval in this study.

Uncertain results on side effects and quality of life

Data were available for the following outcomes: overall survival, time to first skeletal-related complication, adverse events and health-related quality of life. However, the results on severe and serious adverse events (e.g. pain), on discontinuation due to such events and on occurrence of diarrhoea were uncertain. The data on health-related quality of life presented by the manufacturer were either not evaluable (EQ-5D) or subject to great uncertainty (FACT-P).

Extent of survival advantage depends on age

Patients in the radium-223 arm of the study survived longer than patients in the control group, but the extent of added benefit depends on age: For men younger than 65 years, there was an indication of a major added benefit of radium-223. For patients aged over 65 years, only an indication of a minor added benefit could be determined.

Bone symptoms occurred later

Radium-223 also had advantages for the patients with regards to the burden of disease (morbidity). Bone symptoms occurred considerably later in men who were treated with radium-223 + BSC than under BSC treatment alone. Concomitant treatment with bisphosphonates played a role for the extent of added benefit: For patients with bisphosphonate treatment, there was an indication of a major added benefit, whereas for patients without this concomitant treatment, there was only a hint of a non-quantifiable (no more than considerable) added benefit of radium-223 with BSC compared with BSC.

Fewer side effects in most patients

Most of the patients who were treated with radium-223 also had fewer side effects: With regards to serious/severe side effects, there were no more than indications of lesser harm from radium-223 + BSC compared with BSC with the extent of no more than "minor". This lesser harm was presumably due to side effects caused by an increased use of drugs (e.g. analgesics) in the placebo + BSC group.

This was offset by a hint of considerably greater harm from radium-223 + BSC due to more frequent, but never severe, diarrhoea in patients without docetaxel pretreatment. This greater harm did not raise doubts about the overall assessment.

Overall assessment: added benefit only for one patient population

Overall, there was an added benefit in the BSC population, which depended on age and concomitant bisphosphonate treatment: IQWiG determined an indication of a major added benefit of radium-223 + BSC versus BSC as appropriate comparator therapy in patients younger than 65 years and in patients older than 65 years who were treated with bisphosphonate. An indication of a minor added benefit of radium-223 can be derived for patients older than 65 years without concomitant bisphosphonate treatment.

In this overall assessment, the longer overall survival, the delay in the occurrence of bone symptoms and fewer side effects were decisive for the added benefit of radium-223 + BSC compared with BSC.

There were no evaluable data for the docetaxel population. Hence an added benefit of radium-223 is not proven for this subpopulation.

G-BA decides on the extent of added benefit

The dossier assessment is part of the overall procedure for early benefit assessments supervised by the G-BA. After publication of the manufacturer's dossier and IQWiG's assessment, the G-BA conducts a commenting procedure, which may provide further information and result in a change to the benefit assessment. The G-BA then decides on the extent of the added benefit, thus completing the early benefit assessment.

INFORMATION: An overview of the results of IQWiG's benefit assessment is given by a German-language executive summary. In addition, the website » http://www.gesundheitsinformation.de, published by IQWiG, provides easily understandable and brief German-language information on radium-223 dichloride.

The G-BA website contains both general English-language information on benefit assessment pursuant to §35a Social Code Book (SGB) V and specific German-language information on the assessment of radium-223 dichloride. More English-language information will be available soon (Sections 2.1 to 2.6 of the dossier assessment as well as subsequently published health information on » http://www.informedhealthonline.org).

If you would like to be informed when these documents are available, please send an e-mail to » info@iqwig.de.


ELSE PRESS RELEASES FROM THIS DATE:

Nanoparticles cause cancer cells to self-destruct

2014-04-03
Using magnetically controlled nanoparticles to force tumour cells to 'self-destruct' sounds like science fiction, but could be a future part of cancer treatment, according to research from Lund University in Sweden. Watch video:https://www.youtube.com/watch?v=vos0QW2Yclk&feature=youtu.be "The clever thing about the technique is that we can target selected cells without harming surrounding tissue. There are many ways to kill cells, but this method is contained and remote-controlled", said Professor Erik Renström. The point of the new technique is that it is much more ...

Tiny power generator runs on spit

Tiny power generator runs on spit
2014-04-03
Saliva-powered micro-sized microbial fuel cells can produce minute amounts of energy sufficient to run on-chip applications, according to an international team of engineers. Bruce E. Logan, Evan Pugh Professor and Kappe Professor of Environmental Engineering, Penn State, credited the idea to fellow researcher Justine E. Mink. "The idea was Justine's because she was thinking about sensors for such things as glucose monitoring for diabetics and she wondered if a mini microbial fuel cell could be used," Logan said. "There is a lot of organic stuff in saliva." Microbial ...

Attracting wild bees to farms is a good insurance policy

Attracting wild bees to farms is a good insurance policy
2014-04-03
EAST LANSING, Mich. -- Investing in habitat that attracts and supports wild bees in farms is not only an effective approach to helping enhance crop pollination, but it can also pay for itself in four years or less, according to Michigan State University research. The paper, published in the current issue of the Journal of Applied Ecology, gives farmers of pollination-dependent crops tangible results to convert marginal acreage to fields of wildflowers, said Rufus Isaacs, MSU entomologist and co-author of the paper. "Other studies have demonstrated that creating flowering ...

Pulmonary hypertension deaths have increased over past decade according to CDC report in CHEST

2014-04-03
Deaths from pulmonary hypertension have increased over the past decade, according to a study from the Centers for Disease Control and Prevention (CDC). In the study, published online in CHEST, researchers analyzed death rates from the National Vital Statistics System and data from the National Hospital Discharge Survey between 2001 and 2010 to analyze trends in hospitalizations and death rates related to pulmonary hypertension. Pulmonary hypertension is characterized by increased blood pressure in the pulmonary arteries, causing the right side of the heart to work ...

Tiny biomolecular tweezers studying force effect of cells

Tiny biomolecular tweezers studying force effect of cells
2014-04-03
A new type of biomolecular tweezers could help researchers study how mechanical forces affect the biochemical activity of cells and proteins. The devices — too small to see without a microscope — use opposing magnetic and electrophoretic forces to precisely stretch the cells and molecules, holding them in position so that the activity of receptors and other biochemical activity can be studied. Arrays of the tweezers could be combined to study multiple molecules and cells simultaneously, providing a high throughput capability for assessing the effects of mechanical forces ...

Enhancing the immune response through next generation polymeric vaccine adjuvants

Enhancing the immune response through next generation polymeric vaccine adjuvants
2014-04-03
The great success of vaccines over the past two centuries as a preventive medicine has led to a significant reduction in morbidity and death caused by controllable infectious diseases. The effectiveness of vaccines is dependent on their ability to induce a protective immune response in recipients. Adjuvants, such as aluminum salts, have been integrated into vaccines for more than 70 years to augment the body's immune response to patho-gens. Adjuvants are especially necessary to boost the immune response for subunit vac-cines. However, conventional adjuvants are limited ...

Diffeomorphometry and geodesic positioning systems for human anatomy

Diffeomorphometry and geodesic positioning systems for human anatomy
2014-04-03
A team of researchers from the Center for Imaging Science at the Johns Hopkins University and the CMLA of the École Normale Supérieure Cachan have demonstrated new algorithmic technologies for the parametric representation of human shape and form. Coupled with advanced imaging technologies, this presents opportunities for tracking soft-tissue deformations associated with cardiovascular studies, radiation treatment planning in Oncology, and neurodegenerative brain illnesses. The software algorithms provide tools for basic science and pre-clinical investigations for synchronizing ...

Structural insights into the inner workings of a viral nanomachine

Structural insights into the inner workings of a viral nanomachine
2014-04-03
Researchers at the Virginia Tech Carilion Research Institute (VTCRI) are using new nanoscale imaging approaches to shed light on the dynamic activities of rotaviruses, important pathogens that cause life-threatening diarrhea in young children. Once a rotavirus enters a host cell, it sheds its outermost protein layer, leaving behind a double-layered particle (DLP). These DLPs are the form of the virus that produces messenger RNA molecules, which are critical for launching the infection. Researchers, Deborah Kelly, Ph.D. and Sarah McDonald, Ph.D., both Assistant Professors ...

A pocket-size ultrasonic nebulizer employing a novel nozzle improves inhalers

A pocket-size ultrasonic nebulizer employing a novel nozzle improves inhalers
2014-04-03
Inhalation is an increasingly important route for non-invasive drug delivery for both systemic and local applications. Control of particle size and output plays a critical role in the efficient and effective delivery of oft en expensive medications to the lung. Drugs designed to treat pulmonary diseases or for systemic absorption through the alveolar capillary bed require optimum particle sizes (1 to 6 μm) for effective delivery. A team of researchers from the Department of Electrical Engineering and Computer Science at the University of California, Irvine has realized ...

An ethics framework should be used to decide health standards for extended, exploratory spaceflights

2014-04-03
WASHINGTON – NASA should use an ethics framework when deciding whether, and under what conditions, spaceflights that venture outside low Earth orbit or extend beyond 30 days are acceptable if they do not meet current health standards, says a new report from the Institute of Medicine, the health arm of the National Academy of Sciences. Exceptions to existing health standards should be granted by NASA on a mission-by-mission basis, and any exceptions should be rare and occur only in extenuating circumstances. The report provides an ethics framework based on six principles ...

LAST 30 PRESS RELEASES:

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce

Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes

New research expands laser technology

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers

Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes

CTE and normal aging are difficult to distinguish, new study finds

Molecular arms race: How the genome defends itself against internal enemies

Tiny chip speeds up antibody mapping for faster vaccine design

KTU experts reveal why cultural heritage is important for community unity

More misfolded proteins than previously known may contribute to Alzheimer’s and dementia

“Too much going on”: Autistic adults overwhelmed by non-verbal social cues

What’s driving America’s deep freezes in a warming world?

A key role of brain protein in learning and memory is deciphered by scientists

Heart attacks don’t follow a Hollywood script

Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories

Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds

Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%

Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR

New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications

State gun laws and firearm-related homicides and suicides

Use of tobacco and cannabis following state-level cannabis legalization

Long-term obesity and biological aging in young adults

Eindhoven University of Technology and JMIR Publications announce unlimited open access publishing agreement

Orphan nuclear receptors in metabolic dysfunction-associated steatotic liver disease development

A technological breakthrough for ultra-fast and greener AI

Pusan National University researchers identify key barriers hindering data-driven smart manufacturing adoption

Inking heterometallic nanosheets: A scalable breakthrough for coating, electronics, and electrocatalyst applications

[Press-News.org] Radium-223 dichloride in prostate cancer: Major added benefit for certain patients
In comparison with BSC: Patients survive longer and get bone symptoms later / no evaluable data in comparison with docetaxel